Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc.

KLTOW - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$217.62K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Klotho Neurosciences, Inc.Klotho Neurosciences, Inc.-0.5--38%--
$-0.01

Current Fair Value

112.6% downside

Overvalued by 112.6% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$217,616.00
Enterprise Value$-8,828,773.00
Earnings per Share$-11
Beta2.24
Outstanding Shares2,530,423

Return

Return on Equity-37.59%ROE
Return on Assets-33.48%
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-0.47P/E Ratio
PEG4.72PEG
Price to Sales-Price to Sales
Price to Book Ratio0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income0
Total Debt to Enterprise0.01
Debt to Equity0.01Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Redwoods Acquisition Corp

5 employees
CEO: Joseph A. Sinkule

Greenland Mines Ltd operates across two segments: natural resources and cell and gene therapy. Its resources arm is focused on exploring for palladium, gold, and platinum, centered on the exploration and development of the Skaergaard pro...

Klotho Neurosciences Insider Information FAQ

Stockcircle shows 4 open-market insider purchases and 2 open-market insider sales for Klotho Neurosciences in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.